ASX Announcements
- May 22nd, 2024 - Strategic Review Update & Variation of MD Employment Terms
- May 22nd, 2024 - Notice of General Meeting, Proxy Form
- May 22nd, 2024 - Letter to Shareholders – Notice of General Meeting
- April 12th, 2024 - Appendix 3G – Notification of Issue, Conversion or Payment Up of Unquoted Equity Securities
- April 12th, 2024 - Cleansing Prospectus
- April 12th, 2024 - Appendix 2A – Application for Quotation of Securities
- April 9th, 2024 - Appendix 3B – Proposed Issue of Securities
- February 5th, 2024 - Nuheara Limited (ASX: NUH) Q2 FY24 Webinar
- January 31st, 2024 - December 2023 (Q2 FY24) Quarterly Activities Report
- January 31st, 2024 - December 2023 (Q2 FY24) Quarterly Appendix 4C
- January 18th, 2024 - Nuheara Showcases Next-Gen Product at CES to Support 38 Million Americans with Hearing Loss
- November 22nd, 2023 - Annual General Meeting – Managing Director’s Presentation
- November 22nd, 2023 - Final Director’s Interest Notice – D. Cannington
- November 22nd, 2023 - Non-executive Director Retirement
- November 22nd, 2023 - Change in substantial holding
- November 22nd, 2023 - Results of Annual General Meeting
- November 17th, 2023 - Change of Director’s Interest Notice x 4
- November 17th, 2023 - Application for quotation of securities – NUH
- November 17th, 2023 - Notification of cessation of securities – NUH
- November 13th, 2023 - Application for quotation of securities – NUH
- November 13th, 2023 - Application for quotation of securities – NUH
- November 8th, 2023 - Successful Completion of Retail Entitlement Offer
- October 31st, 2023 - September 2023 Quarterly Activities Report
- October 31st, 2023 - September 2023 Quarterly Appendix 4C
- October 25th, 2023 - Extension of Closing Date for Retail Entitlement Offer
- October 25th, 2023 - Appendix 3B – Proposed Issue of Securities – NUH – Update
- October 10th, 2023 - Notification to Optionholders – Entitlement Offer
- October 10th, 2023 - Prospectus
- October 10th, 2023 - Entitlement Offer Presentation – October 2023
- October 10th, 2023 - Proposed issue of securities – NUH
- October 10th, 2023 - NUH Capital Raising To Support Expansion With US Retailers
- October 10th, 2023 - Trading Halt
- September 29th, 2023 - Annual Report
- September 29th, 2023 - Appendix 4G and Corporate Governance Statement
- September 15th, 2023 - Change of Registry Address Notification
- September 15th, 2023 - 2023 Annual General Meeting – Key Dates
- September 4th, 2023 - Investor Presentation
- August 30th, 2023 - Nuheara Investor Briefings
- August 29th, 2023 - NUH Accelerates Expansion with US Retailers Inc. Walmart
- August 29th, 2023 - Appendix 4E – Preliminary Final Report
- August 25th, 2023 - Notification of cessation of securities – NUH
- August 10th, 2023 - Cleansing Prospectus
- August 10th, 2023 - Application for quotation of securities – NUH
- August 3rd, 2023 - Nuheara Limited (ASX: NUH) Q4 FY23 Webinar [Video Presentation]
- August 1st, 2023 - Nuheara Q4 FY23 Business Update
- July 31st, 2023 - June 2023 Quarterly Activities Report
- July 31st, 2023 - June 2023 Quarterly Appendix 4C
- July 20th, 2023 - Results of Meeting
- July 18th, 2023 - Key Appointment Completes Restructure of Executive Team
- July 14th, 2023 - Change of Auditor
- June 29th, 2023 - Change in substantial holding
- June 20th, 2023 - Change in substantial holding
- June 16th, 2023 - Letter to Shareholders – Notice of General Meeting
- June 16th, 2023 - Notice of General Meeting/Proxy Form
- June 13th, 2023 - Cleansing Prospectus
- June 13th, 2023 - Notification of cessation of securities – NUH
- June 13th, 2023 - Notification regarding unquoted securities – NUH
- June 13th, 2023 - Application for quotation of securities – NUH
- June 6th, 2023 - Proposed issue of securities – NUH
- June 5th, 2023 - Trading Halt
- May 11th, 2023 - Change in substantial holding
- May 11th, 2023 - Change in substantial holding
- May 11th, 2023 - Becoming a substantial holder
- May 3rd, 2023 - Ceasing to be a substantial holder
- April 28th, 2023 - March 2023 Quarterly Activities Report
- April 28th, 2023 - March 2023 Quarterly Appendix 4C
- April 28th, 2023 - Nuheara Limited (ASX: NUH) Q3 FY23 Update [Audio Recording]
- April 26th, 2023 - Nuheara Q3 FY23 Business Update
- April 24th, 2023 - Results of General Meeting
- April 19th, 2023 - Nuheara Continues US Retail Expansion with CVS Health
- March 24th, 2023 - Change in substantial holding
- March 24th, 2023 - Letter to Shareholders – Notice of General Meeting
- March 24th, 2023 - Notice of General Meeting/Proxy Form
- March 17th, 2023 - Change in substantial holding
- March 15th, 2023 - Initial Director’s Interest Notice – L. Liu
- March 15th, 2023 - Change in substantial holding
- March 14th, 2023 - Cleansing Prospectus
- March 14th, 2023 - Application for quotation of securities – NUH
- March 14th, 2023 - Nuheara Appoints Leroy Liu to Board of Directors
- March 14th, 2023 - Proposed issue of securities – NUH
- March 9th, 2023 - H1 FY23 – Nuheara Delivers on US Regulated Market Strategy
- March 8th, 2023 - Reinstatement to Quotation
- March 8th, 2023 - Corporate Presentation
- March 8th, 2023 - Proposed issue of securities – NUH
- March 8th, 2023 - Successful Capital Raising of $3M to Underpin US Growth
- March 8th, 2023 - Appendix 4D and Half Year Financial Report
- March 1st, 2023 - Suspension from Quotation
- February 28th, 2023 - Nuheara Expands with Target.com in the US and Ships HP Hearing PRO
- February 21st, 2023 - Nuheara To Distribute HP Hearing PRO Through Fuel Medical
- February 16th, 2023 - Nuheara Commences Mass Production of HP Hearing PRO with Shipping Expected this Month
- February 8th, 2023 - Quarterly Activities Report and Appendix 4C, 31 December 2022
- January 31st, 2023 - Quarterly Activities Report and Appendix 4C
- January 10th, 2023 - Becoming a substantial holder
- January 4th, 2023 - Change in substantial holding
- December 22nd, 2022 - Nuheara raises over $3 MILLION to underpin US growth. – 22 December 2022
- December 12th, 2022 - Nuheara Expands U.S. Retail Footprint with InnerScope Strategic Partnership – 12 December 2022
- November 2nd, 2022 - Nuheara (NUH) Investor Briefing – SYD Nov 2, 2022 Canberra, Melbourne, Sydney
- November 1st, 2022 - 2023 FY Q1 Results – Webinar 31 October 2022
- October 31st, 2022 - Quarterly Activities Report and Appendix 4C – 31 October 2022
- October 12th, 2022 - Change in substantial holding – 12 October 2022
- October 6th, 2022 - 2022 AGM Key Dates – 06 OCTOBER 2022
- September 16th, 2022 - Appendix 3G: Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
- September 8th, 2022 - Nuheara Announces $2.5Million Follow-on Funding From Realtek – 08 September 2022
- September 5th, 2022 - Nuheara Limited (ASX: NUH) – Suspension from Quotation – 05 September 2022
- September 1st, 2022 - Nuheara Limited ASX:NUH – Trading Halt 01 September 22.
- August 23rd, 2022 - Results of General Meeting of Shareholders, 22 August 2022
- August 17th, 2022 - US OTC HEARING AID MARKET TO OPEN FOR NUHEARA
- July 29th, 2022 - Quarterly Activities and Cash Flow Report – quarter ended 30 June 2022
- July 29th, 2022 - Becoming a substantial holder
- July 27th, 2022 - Notice of Initial Substantial Holder
- July 27th, 2022 - Appendix 2A – Application for the Quotation of Shares
- July 27th, 2022 - s708A Cleansing Notice
- July 27th, 2022 - Quarterly Activities and Cash Flow Report – Quarter ended 30 June 2022
- July 22nd, 2022 - APPOINTMENT OF AUDITOR
- July 21st, 2022 - NOTICE OF GENERAL MEETING AND EXPLANATORY MEMORANDUM TO SHAREHOLDERS
- July 21st, 2022 - GENERAL MEETING – NOTICE AND PROXY FORM
- July 19th, 2022 - Appendix 2A: Realtek
- July 19th, 2022 - Appendix 2A: Bergen Share Issue
- July 18th, 2022 - Appendix 2A: Directors’ Salary Sacrifice Shares
- July 16th, 2022 - Appendix 3Y: Change of Directors’ Interest Notice x 4
- July 16th, 2022 - Sec 708A Cleansing Notice
- July 16th, 2022 - Sec 708A Cleansing Notice
- July 6th, 2022 - Notification of cessation of securities – NUH
- July 1st, 2022 - Section 708A(5)(e) Notice
- July 1st, 2022 - NUH Strategic Partner & Cornerstone
- July 1st, 2022 - Reinstatement to Official Quotation
- July 1st, 2022 - Application for quotation of securities – NUH
- June 8th, 2022 - Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
- May 25th, 2022 - AGREEMENT FOR THE SALE OF NON-CORE MINING ROYALTY
- May 24th, 2022 - Appendix 4C: Quarter Ended 31 March 2022 – Amended
- May 9th, 2022 - Nuheara Announces New CEO and Roth Capital to Explore US Listing
- May 3rd, 2022 - 2022 FY Q3 Results – Webinar & Presentation Slides
- May 3rd, 2022 - Quarterly Activities Report and Appendix 4C
- April 29th, 2022 - Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
- April 27th, 2022 - RESULTS OF GENERAL MEETING OF SHAREHOLDERS
- April 27th, 2022 - Section 708A(5)(e) Notice
- April 27th, 2022 - Appendix 2A – Application for Quotation of Securities
- April 26th, 2022 - Nuheara Enters Worldwide Trademark License Agreement With HP Inc.
- April 12th, 2022 - NUHEARA SUBMITS 510(k) FOR U.S. FDA CLEARANCE
- March 28th, 2022 - Notification of Consolidation/Split – NUH
- March 25th, 2022 - Notice Of General Meeting & Explanatory Memorandum to Shareholders
- March 25th, 2022 - Appendix 3H Notification of Cessation of Securities
- February 28th, 2022 - Nuheara Well Placed To Grow – Half Year Ended 31 December 2021
- February 16th, 2022 - NUHEARA EXPANDS US OPERATIONS TO CAPTURE REGULATED HEARING MARKET OPPORTUNITY
- February 9th, 2022 - S708A(5)(e) Cleansing Notice
- February 9th, 2022 - Appendix 2A – Application for Quotation of Securities
- February 1st, 2022 - 2022FY Q2 Results – Webinar & Presentation Slides
- February 1st, 2022 - Clinical Trial Validates Hearing Benefits of Nuheara’s Self-Fitted Hearing Aids & Software
- January 31st, 2022 - Quarterly Activities Report – For the quarter ended 31 December 2021
- January 28th, 2022 - Q2 FY22 Business Update and Investor Briefing Details
- January 28th, 2022 - Appendix 3Y – Change of Director’s Interest Notice
- January 25th, 2022 - Appendix 2A – Application for quotation of securities
- January 24th, 2022 - Nuheara Completes Share Purchase Plan
- January 6th, 2022 - Nuheara Clinical Trial and FDA 510(K) Pathway Update
- January 5th, 2022 - Section 708A(5)(e) Notice (cleansing notice)
- January 5th, 2022 - Appendix 2A – Application for quotation of securities
- January 4th, 2022 - Appendix 3B – CN Cap Raising & SPP_231221
- January 4th, 2022 - Nuheara Undertakes Capital Raising to Support Growth